Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer
Status:
Completed
Trial end date:
2018-04-04
Target enrollment:
Participant gender:
Summary
Single-arm study to determine disease control rate in second- (or later) line treatment with
cabazitaxel after the failure of palliative primary treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest Prof. Dr. S.E. Al-Batran